Investor Presentation

Valiant Organics, a specialty chemicals manufacturer, reported FY25 revenue of ₹719 Cr, a slight dip from ₹723 Cr in FY24. Dyes & Pigments (52%) and Agro Chemicals (25%) are top revenue drivers, utilizing key chemistries like Hydrogenation (47%) and Ammonolysis (28%). The company strategically targets specialty chemicals facing high demand, low supply, and import reliance.

Its strengths lie in a diverse product range, integrated operations, and strong customer relationships across Pharmaceuticals, Dyes, and Agrochemicals.

Notably, Valiant Laboratories Limited transitioned from a subsidiary to an associate in October 2023 following its IPO.

Financially, Valiant saw EBITDA improve to ₹54 Cr (7.47% margin) in FY25, up from ₹38 Cr (5.28%) in FY24. Net Loss narrowed to ₹3 Cr (-0.47% margin) from ₹8 Cr loss (-1.16%) previously.

Net Debt to Equity stands at 0.33x. Management's focus appears to be on leveraging its robust business model and domain expertise for operational efficiency and sustainable growth.